During financial year 2025-26, 03 State Drug Testing Laboratories (DTLs) have been supported financially under the Ayush Oushadhi Gunavatta evam Uttpadan Samvardhan Yojana (AOGUSY) scheme. The details of total amount of funds allocated, released and utilised for upgrading State DTLs under the AOGUSY scheme during 2025-26, State/UT-wise are attached at Annexure.
There is no such report available with the ministry regarding shortage of contractual staff in the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). Further, as reported by State Licensing Authorities, there is no acute shortage of contractual staff.
However, WHO Certificate of Pharmaceutical Product (WHO-CoPP) to Ayush drugs is issued by Central Drugs Standard Control Organization (CDSCO). Further e-Aushadhi portal (www.e-aushadhi.gov.in) is being implemented by Ministry of Ayush for all Licensing related activities of Ayush drugs to improve transparency, reduce processing delays and facilitate real-time monitoring of applications and certifications. Respective State/UT Licensing Authorities can issue license to the manufacturers to manufacture for sale of Ayurveda, Siddha, Sowa-Rigpa, Unani and Homoeopathy medicines through e-Aushadhi portal as per the provisions of the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945.
As reported by the State Govt. of Chhattisgarh, there are 34 Ayush Drug Inspectors available in Chhattisgarh, while the State has one Drug Testing Laboratory (DTL) in Raipur with the requisite testing facilities. There is no specific shortfall in manpower and DTL infrastructure. The Ministry of Ayush is regularly coordinating with the State Government and other concerned stakeholders to strengthen the regulatory and drug testing ecosystem in the State, including the Aspirational Districts.
Ministry of Ayush is implementing the central sector scheme namely, Ayush Oushadhi Gunavatta evam Uttpadan Samvardhan Yojana (AOGUSY), which provides 100% grant-in-aid for upgrading and strengthening State/UT DTL including procurement and upgradation of high-end analytical equipment. An Ayush vertical has been established in Central Drugs Standard Control Organization (CDSCO) to strengthen regulatory measures ensuring safety and quality of Ayush drugs. As per the existing guidelines, WHO Certificate of Pharmaceutical Product (WHO-CoPP) to Ayush drugs is issued by Central Drugs Standard Control Organization (CDSCO) after joint inspections of manufacturing units by Drug Inspectors posted in Ayush vertical along with drug inspectors of State/UTs and CDSCO for compliance with WHO Technical Report Series (TRS) guidelines for Herbal Medicines.
Annexure
The details of total amount of funds allocated, released and utilised for upgrading State DTLs under the AOGUSY during 2025-26, State/UT-wise are as follows-
- Amount Allocated under GIA head of the AOGUSY (for upgrading DTLs and Pharmacies) during 2025-26 is Rs 17.50 Crore.
- Amount of funds released and utilised for upgrading State DTLs is as mentioned below-
(Amount in Rs)
|
S. No.
|
State
|
Component
|
Govt./Pvt./PSU
|
Particulars
|
Total amount Sanctioned
|
Amount Released in previous years
|
Amount Released in 2025-26
|
Expenditure incurred 2025-26
|
|
1.
|
Arunachal Pradesh
|
Strengthening and up-gradation of Ayush Pharmacies and Drug Testing Laboratories to achieve higher standards
|
Govt.
|
State Govt. DTL
|
53,24,026
|
2023-24
17,99,813
2024-25
17,24,400
|
17,99,813
|
17,99,813
|
|
2.
|
Mizoram
|
Govt.
|
State Govt. DTL
|
1,60,61,384
|
2021-22-
18,00,000
2023-24
67,20,884
2024-25
57,40,500
|
18,00,000
|
14,19,928
|
|
3.
|
Madhya Pradesh
|
Govt.
|
State Govt. DTL
|
75,83,262
|
-
|
75,83,262
|
-
|
This information was given by Union Minister of State (I/C) for Ayush, Shri Prataprao Jadhav in a written reply in Lok Sabha today.
***
SR/SV/SG